Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M. Sperger, Joshua M. Lang, Hamid Emamekhoo et al.|Journal of Clinical Oncology|2021Cited by 62
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M. Sperger, Joshua M. Lang, Kyle T. Helzer et al.|Clinical Cancer Research|2023Cited by 56
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Hamza Bakhtiar et al.|Journal of Clinical Investigation|2022Cited by 33
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extractionHannah M. Pezzi, David J. Beebe, David J. Guckenberger et al.|Lab on a Chip|2018Cited by 25
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M. Bade, Joshua M. Lang, Jennifer L. Schehr et al.|Molecular Oncology|2021Cited by 24